Clinical trial
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
NCT00041938 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
- Lead sponsor
- Columbia University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2002
- Completion date
- July 31, 2014
- Enrollment
- 2,305 (actual)
- Sites
- 64
Conditions
As the registry lists them; a condition with its own page is linked.
heart disease, ischemic heart disease, myocardial infarction, stroke